Ikapharmindo Putramas Tbk PT
IDX:IKPM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
193
284
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Ikapharmindo Putramas Tbk PT
Net Income (Common)
Ikapharmindo Putramas Tbk PT
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Ikapharmindo Putramas Tbk PT
IDX:IKPM
|
Net Income (Common)
Rp5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Victoria Care Indonesia Tbk PT
IDX:VICI
|
Net Income (Common)
Rp175.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
M
|
Martina Berto Tbk PT
IDX:MBTO
|
Net Income (Common)
-Rp24.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
|
Net Income (Common)
Rp1.2T
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
|
Kino Indonesia Tbk PT
IDX:KINO
|
Net Income (Common)
Rp137.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Mandom Indonesia Tbk PT
IDX:TCID
|
Net Income (Common)
-Rp4.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Ikapharmindo Putramas Tbk PT
Glance View
Ikapharmindo Putramas Tbk PT is a ID-based company operating in Personal Care Products industry. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 983 full-time employees. The company went IPO on 2023-11-08. PT Ikapharmindo Putramas Tbk. is an Indonesia-based company, which is engaged in the marketing of pharmaceutical products and consumer health products located in Jakarta, Indonesia. The firm operates through two segments: Non Pharma, Pharma, and Contract manufacturing. The firm is focused on a diverse portfolio for the Indonesian market, with brands in the pharmaceutical product categories of prescription medicines, over the counter (OTC), nutraceuticals, professional hair care products and baby products. Its prescription pharmaceuticals include neurology, dermatology, gastroenterology, and cardiology. Its consumer division products consist of professional and retail haircare products, and also Baby HUKI, which consists of baby bottles and pacifiers, and other baby feeding equipment.
See Also
What is Ikapharmindo Putramas Tbk PT's Net Income (Common)?
Net Income (Common)
5B
IDR
Based on the financial report for Dec 31, 2024, Ikapharmindo Putramas Tbk PT's Net Income (Common) amounts to 5B IDR.
What is Ikapharmindo Putramas Tbk PT's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-15%
Over the last year, the Net Income (Common) growth was -67%. The average annual Net Income (Common) growth rates for Ikapharmindo Putramas Tbk PT have been -15% over the past three years .